Margaret “Meg” S.J. Willis, Ph.D., focuses her practice on patent prosecution, including drafting and prosecuting patent applications, prior art searches, freedom to operate studies, and patentability and infringement analyses.
With a wide range of technological expertise in the life sciences, Meg leads the firm’s sequencing group and is skilled in biotechnology, developmental biology, genetics and genetic diseases, CRISPR, gene therapy, molecular biology, signal transduction, biochemical and molecular techniques, biomedical imaging, cell culture techniques, genetic engineering and manipulation, cancer biology, mouse model development and maintenance, immunology and immunotherapeutics, and biomolecule-polymer conjugates.